Holley R W, Armour R, Baldwin J H, Greenfield S
Cell Biol Int Rep. 1983 Feb;7(2):141-7. doi: 10.1016/0309-1651(83)90027-9.
A kidney epithelial cell growth inhibitor, isolated from BSC-1 cell-conditioned medium, has been found to be active on certain lung and mammary gland cell lines in culture. The most responsive cell observed thus far is the CCL64 mink lung cell line. With CCL64 cells, 60% inhibition of [3H]thymidine incorporation is observed at a 0.1 nanogram/ml concentration of the growth inhibitor, and approximately 95% inhibition at 1 nanogram/ml. A human mammary tumor cell line, Hs578T, shows 75% inhibition of [3H]thymidine incorporation, in cell culture. Preliminary studies indicate that injection of the kidney epithelial cell growth inhibitor in vivo into human mammary carcinomas growing in nude mice inhibits [3H]thymidine incorporation in the tumors.
从BSC - 1细胞条件培养基中分离出的一种肾上皮细胞生长抑制剂,已发现其对培养中的某些肺和乳腺细胞系具有活性。迄今为止观察到的反应最灵敏的细胞是CCL64水貂肺细胞系。对于CCL64细胞,在生长抑制剂浓度为0.1纳克/毫升时,观察到[3H]胸腺嘧啶核苷掺入受到60%的抑制,在1纳克/毫升时约95%的抑制。人乳腺肿瘤细胞系Hs578T在细胞培养中显示[3H]胸腺嘧啶核苷掺入受到75%的抑制。初步研究表明,将肾上皮细胞生长抑制剂体内注射到裸鼠体内生长的人乳腺癌中,可抑制肿瘤中[3H]胸腺嘧啶核苷的掺入。